We are live on ! Find out more
BFG

Bleakley Financial Group Portfolio holdings

AUM $6.39B
1-Year Est. Return 26.33%
This Fund
S&P 500
This Quarter Est. Return
+5.7%
1 Year Est. Return
+26.33%
3 Year Est. Return
+77.54%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.2B
AUM Growth
+$209M
Cap. Flow
+$66.4M
Cap. Flow %
2.07%
Top 10 Hldgs %
28.66%
Holding
997
New
87
Increased
510
Reduced
305
Closed
71

Top Buys

Rank Stock Value
1
VO icon
Vanguard Morningstar Mid-Cap ETF
VO
+$6.61M
2
HCA icon
HCA Healthcare
HCA
+$6M
3
VV icon
Vanguard Morningstar Large-Cap ETF
VV
+$5.92M
4
VT icon
Vanguard Total World Stock ETF
VT
+$4.48M
5
PG icon
Procter & Gamble
PG
+$3.69M

Top Sells

Rank Stock Value
1
APLS
Apellis Pharmaceuticals
APLS
+$8.9M
2
A icon
Agilent Technologies
A
+$6.86M
3
BSV icon
Vanguard Short-Term Bond ETF
BSV
+$6.58M
4
AAPL icon
Apple
AAPL
+$6.17M
5
ABT icon
Abbott
ABT
+$5.81M

Sector Composition

Rank Sector Weight
1 Technology 11.85%
2 Healthcare 10.44%
3 Financials 5.01%
4 Consumer Discretionary 4.57%
5 Communication Services 3.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
POWW icon
901
Outdoor Holding Co
POWW
$247M
$54.8K ﹤0.01%
25,723
-129
-0.5% -$252
PGEN icon
902
Precigen
PGEN
$2.2B
$49.7K ﹤0.01%
43,191
+4,121
+11% +$4.87K
OLPX
903
DELISTED
Olaplex Holdings
OLPX
$43.9K ﹤0.01%
+11,796
New +$43.3K
ADMA icon
904
ADMA Biologics
ADMA
$1.95B
$40.7K ﹤0.01%
11,022
-340
-3% -$1.26K
CTEV
905
Claritev Corp
CTEV
$402M
$40.1K ﹤0.01%
475
+27
+6% +$1.44K
COMP icon
906
Compass
COMP
$8.51B
$37.4K ﹤0.01%
10,672
-1,572
-13% -$5.16K
TRUE
907
DELISTED
TrueCar
TRUE
$36.4K ﹤0.01%
16,126
-2,481
-13% -$5.91K
NN icon
908
NextNav
NN
$1.81B
$36K ﹤0.01%
12,261
– –
DNA icon
909
Ginkgo Bioworks
DNA
$515M
$30.6K ﹤0.01%
+411
New +$24.3K
KPTI icon
910
Karyopharm Therapeutics
KPTI
$53.3M
$28.6K ﹤0.01%
+1,064
New +$45.8K
CANO
911
DELISTED
Cano Health, Inc.
CANO
$25.6K ﹤0.01%
184
-59
-24% -$7.57K
TDAY
912
USA Today Co
TDAY
$1.26B
$24.7K ﹤0.01%
+10,963
New +$21.9K
LUMN icon
913
Lumen
LUMN
$6.7B
$24.4K ﹤0.01%
10,807
-3,928
-27% -$8.65K
WE
914
DELISTED
WeWork Inc.
WE
$22.2K ﹤0.01%
+2,176
New +$30.1K
NKTX icon
915
Nkarta
NKTX
$149M
$22.2K ﹤0.01%
+10,127
New +$44.5K
MTNB icon
916
Matinas BioPharma
MTNB
$1.92M
$21.6K ﹤0.01%
1,200
– –
CRGE
917
DELISTED
Charge Enterprises, Inc. Common Stock
CRGE
$20.1K ﹤0.01%
20,555
-1,569
-7% -$1.59K
CXDO icon
918
Crexendo
CXDO
$223M
$19.4K ﹤0.01%
11,000
– –
GWH icon
919
ESS Tech
GWH
$22.1M
$15.9K ﹤0.01%
+721
New +$13K
NYMX
920
DELISTED
Nymox Pharmaceutical Corp
NYMX
$15.2K ﹤0.01%
80,000
– –
MMAT
921
DELISTED
Meta Materials Inc. Common Stock
MMAT
$11K ﹤0.01%
512
– –
CLOV icon
922
Clover Health Investments
CLOV
$2.23B
$9.95K ﹤0.01%
+11,089
New +$9.84K
SCOR icon
923
Comscore
SCOR
$111M
$8.91K ﹤0.01%
550
– –
ID
924
DELISTED
PARTS iD, Inc.
ID
$8.34K ﹤0.01%
20,000
– –
FXLV
925
DELISTED
F45 Training Holdings Inc.
FXLV
$7.5K ﹤0.01%
+15,000
New +$12.8K
35 36
37
38 39

Similar funds

PCH
PGIM Custom Harvest Newark, New Jersey $6.4B AUM 18.53% 1-Year Est. Return
GT
Glenview Trust Louisville, Kentucky $6.37B AUM 23.72% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return
BFS
Bradley Foster & Sargent Hartford, Connecticut $6.44B AUM 25.27% 1-Year Est. Return
EC
ECP ControlCo Summit, New Jersey $6.34B AUM 19.72% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return
OMC
Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return

Bleakley Financial Group's Q2 2023 Portfolio in Review

As of Q2 2023, Bleakley Financial Group held 997 positions worth $3.2B, up 7% from $3B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Bleakley Financial Group's Q2 2023 filing shows 87 new, 510 increased, 305 reduced and 71 closed positions. Its largest new stake was Monro: 54,860 shares worth $2.23M. The largest sale was Apellis Pharmaceuticals, an estimated $8.9M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.

  • Bleakley Financial Group's largest Q2 2023 buy was Monro: 54,860 shares worth $2.23M.
  • Bleakley Financial Group added most to Vanguard Morningstar Mid-Cap ETF in Q2 2023, an estimated $6.61M increase.
  • Bleakley Financial Group's biggest Q2 2023 reduction was Apellis Pharmaceuticals, cutting an estimated $8.9M.
  • Bleakley Financial Group fully exited ABB Ltd in Q2 2023, selling an estimated $3.61M.
  • Bleakley Financial Group's ten largest holdings make up 29% of its $3.2B portfolio in Q2 2023.
  • Bleakley Financial Group opened 87 new positions and closed 71 in Q2 2023.
  • Bleakley Financial Group's portfolio value rose 7% quarter-over-quarter to $3.2B.

Based on Bleakley Financial Group's 13F filing for Q2 2023, filed 14 Aug 2023.